Latest Breaking News On - Relations media inquiries - Page 1 : vimarsana.com

Sangamo Therapeutics, Inc : Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Sangamo Therapeutics, Inc : Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleJason fontenotIndiens wirtschaftLouise wilkieIhre chancenSangamo therapeutics incCongress presentationsEuropean society of gene cell therapyExchange commissionSangamo therapeuticsEuropean societyGene cell therapyAnnual congressChief scientific officerFinger activatorsPresentation october

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sangamo zfpsVic myerLouise wilkieJason fontenotVerge scientific communicationsSangamo therapeutics incChroma medicine incExchange commissionSangamo therapeuticsChroma medicineChief scientific officerAnnual reportQuarterly reportRelations media inquiriesScientific communicationsDie experten

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Andrew funderburkAlfredw sandrock jrLouise wilkieSandy macraeNeurocrine biosciencesSangamo therapeutics incExchange commissionVoyager therapeutics incPfizer incSangamo therapeuticsVoyager therapeuticsChief executive officerTropism redirectionCell type specific expressionAnnual reportQuarterly report

Sangamo Therapeutics, Inc : Sangamo Therapeutics Announces Appointment of Lisa Rojkjaer, M D , as Chief Medical Officer

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Lisa Rojkjaer, M.D., as Chief Medical Officer. She will serve on the Executive Leadership team

Lisa rojkjaerNathalie dubois stringfellowLouise wilkieGewinn nurBettina cockroftClinical developmentNovo nordiskSangamo therapeutics incGlobal clinical program head at novartis oncologyHead of clinical development at morphosysGlobal medical affairsUniversity of torontoExchange commissionDevelopment officerSangamo therapeuticsChief medical

Sangamo Therapeutics, Inc : Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the

Louise wilkieJason fontenotLos angelesPlatform development for productionAdministration in cynomolgus macaquesSangamo therapeutics incAmerican society of gene cell therapyStrategic formulation developmentExchange commissionSangamo therapeuticsAmerican societyGene cell therapyChief scientific officerMeeting presentationsCentral nervousTherapeutic approach